SAB Biotherapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SABS and other ETFs, options, and stocks.

About SABS

SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company, which engages in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. The firm produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases.

CEO

Samuel J. Reich

CEOSamuel J. Reich

Employees

Employees63

Headquarters

Miami Beach, Florida

HeadquartersMiami Beach, Florida

Founded

2014

Founded2014

Employees

Employees63

SABS Key Statistics

Market cap

31.23M

Market cap31.23M

Price-Earnings ratio

-0.76

Price-Earnings ratio-0.76

Dividend yield

—

Dividend yield—

Average volume

330.89K

Average volume330.89K

High today

$3.09

High today$3.09

Low today

$2.97

Low today$2.97

Open price

$3.06

Open price$3.06

Volume

132.43K

Volume132.43K

52 Week high

$6.60

52 Week high$6.60

52 Week low

$1.00

52 Week low$1.00

Analyst ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own SABS. This list is generated using Robinhood data, and it’s not a recommendation.